FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 355:1199-1209 September 21, 2006 Number 12 Next

	Full Text PDF PDA Full Text PowerPoint Slide Set Supplementary Material Perspective by Schwartz, R. S. Editorial by Rosenzweig, A. Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

ABSTRACT

Background Previous studies have shown improvement in left ventricular function after intracoronary injection of autologous cells derived from bone marrow (BMC) in the acute phase of myocardial infarction. We designed a randomized, controlled trial to further investigate the effects of this treatment.

Methods Patients with acute ST-elevation myocardial infarction of the anterior wall treated with percutaneous coronary intervention were randomly assigned to the group that underwent intracoronary injection of autologous mononuclear BMC or to the control group, in which neither aspiration nor sham injection was performed. Left ventricular function was assessed with the use of electrocardiogram-gated single-photon-emission computed tomography (SPECT) and echocardiography at baseline and magnetic resonance imaging (MRI) 2 to 3 weeks after the infarction. These procedures were repeated 6 months after the infarction. End points were changes in the left ventricular ejection fraction (LVEF), end-diastolic volume, and infarct size.

Results Of the 50 patients assigned to treatment with mononuclear BMC, 47 underwent intracoronary injection of the cells at a median of 6 days after myocardial infarction. There were 50 patients in the control group. The mean (±SD) change in LVEF, measured with the use of SPECT, between baseline and 6 months after infarction for all patients was 7.6±10.4 percentage points. The effect of BMC treatment on the change in LVEF was an increase of 0.6 percentage point (95% confidence interval [CI], –3.4 to 4.6; P=0.77) on SPECT, an increase of 0.6 percentage point (95% CI, –2.6 to 3.8; P=0.70) on echocardiography, and a decrease of 3.0 percentage points (95% CI, 0.1 to –6.1; P=0.054) on MRI. The two groups did not differ significantly in changes in left ventricular end-diastolic volume or infarct size and had similar rates of adverse events.

Conclusions With the methods used, we found no effects of intracoronary injection of autologous mononuclear BMC on global left ventricular function. (ClinicalTrials.gov number, NCT00199823 [ClinicalTrials.gov] .)

Source Information

From the Departments of Cardiology (K.L., S.A., K.E., A.R., K.F.), Nuclear Medicine (J.G.F.), and Radiology (H.J.S., E.H.), and the Institute of Immunology (T.E., E.T., J.E.B.), Rikshospitalet University Hospital; the Departments of Cardiology (S.S., H.A., A.M., R.B.), Cardiovascular Radiology (M.B.), and Nuclear Medicine (C.M.), and the Unit of Epidemiology and Biostatistics, Center for Clinical Research (M.A.), Ullevål University Hospital; and the Institute for Experimental Medical Research, University of Oslo (A.I., H.K.G.) — all in Oslo.

Address reprint requests to Dr. Lunde at the Department of Cardiology, Rikshospitalet University Hospital, 0027 Oslo, Norway, or at ketil.lunde{at}rikshospitalet.no.

Full Text of this Article

This article has been cited by other articles:

• van der Bogt, K. E.A., Sheikh, A. Y., Schrepfer, S., Hoyt, G., Cao, F., Ransohoff, K. J., Swijnenburg, R.-J., Pearl, J., Lee, A., Fischbein, M., Contag, C. H., Robbins, R. C., Wu, J. C. (2008). Comparison of Different Adult Stem Cell Types for Treatment of Myocardial Ischemia. Circulation 118: S121-S129 [Abstract] [Full Text]  
• Silva, E. A., Kim, E.-S., Kong, H. J., Mooney, D. J. (2008). Material-based deployment enhances efficacy of endothelial progenitor cells. Proc. Natl. Acad. Sci. USA 105: 14347-14352 [Abstract] [Full Text]  
• Beeres, S. L M A, Atsma, D. E, van Ramshorst, J., Schalij, M. J, Bax, J. J (2008). Cell therapy for ischaemic heart disease. Heart 94: 1214-1226 [Full Text]  
• Tanabe, S., Sato, Y., Suzuki, T., Suzuki, K., Nagao, T., Yamaguchi, T. (2008). Gene Expression Profiling of Human Mesenchymal Stem Cells for Identification of Novel Markers in Early- and Late-Stage Cell Culture. J Biochem 144: 399-408 [Abstract] [Full Text]  
• Psaltis, P. J., Zannettino, A. C.W., Worthley, S. G., Gronthos, S. (2008). Concise Review: Mesenchymal Stromal Cells: Potential for Cardiovascular Repair. Stem Cells 26: 2201-2210 [Abstract] [Full Text]  
• Lunde, K., Aakhus, S. (2008). Cell therapy in acute myocardial infarction: measures of efficacy. Heart 94: 969-970 [Full Text]  
• Martin-Rendon, E., Brunskill, S. J., Hyde, C. J., Stanworth, S. J., Mathur, A., Watt, S. M. (2008). Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. Eur Heart J 29: 1807-1818 [Abstract] [Full Text]  
• Tossios, P., Krausgrill, B., Schmidt, M., Fischer, T., Halbach, M., Fries, J. W.U., Fahnenstich, S., Frommolt, P., Heppelmann, I., Schmidt, A., Schomacker, K., Fischer, J. H., Bloch, W., Mehlhorn, U., Schwinger, R. H.G., Muller-Ehmsen, J. (2008). Role of balloon occlusion for mononuclear bone marrow cell deposition after intracoronary injection in pigs with reperfused myocardial infarction. Eur Heart J 29: 1911-1921 [Abstract] [Full Text]  
• Chang, S-A, Kim, H-K, Lee, H-Y, Choi, S-Y, Koo, B-K, Kim, Y-J, Sohn, D-W, Oh, B-H, Park, Y-B, Choi, Y-S, Kang, H-J, Kim, H-S (2008). Restoration of left ventricular synchronous contraction after acute myocardial infarction by stem cell therapy: new insights into the therapeutic implication of stem cell therapy for acute myocardial infarction. Heart 94: 995-1001 [Abstract] [Full Text]  
• Carr, C. A., Stuckey, D. J., Tatton, L., Tyler, D. J., Hale, S. J. M., Sweeney, D., Schneider, J. E., Martin-Rendon, E., Radda, G. K., Harding, S. E., Watt, S. M., Clarke, K. (2008). Bone marrow-derived stromal cells home to and remain in the infarcted rat heart but fail to improve function: an in vivo cine-MRI study. Am. J. Physiol. Heart Circ. Physiol. 295: H533-H542 [Abstract] [Full Text]  
• Stone, G. W. (2008). Angioplasty Strategies in ST-Segment-Elevation Myocardial Infarction: Part II: Intervention After Fibrinolytic Therapy, Integrated Treatment Recommendations, and Future Directions. Circulation 118: 552-566 [Full Text]  
• Rota, M., Padin-Iruegas, M. E., Misao, Y., De Angelis, A., Maestroni, S., Ferreira-Martins, J., Fiumana, E., Rastaldo, R., Arcarese, M. L., Mitchell, T. S., Boni, A., Bolli, R., Urbanek, K., Hosoda, T., Anversa, P., Leri, A., Kajstura, J. (2008). Local Activation or Implantation of Cardiac Progenitor Cells Rescues Scarred Infarcted Myocardium Improving Cardiac Function. Circ. Res. 103: 107-116 [Abstract] [Full Text]  
• de Silva, R., Raval, A. N., Hadi, M., Gildea, K. M., Bonifacino, A. C., Yu, Z.-X., Yau, Y. Y., Leitman, S. F., Bacharach, S. L., Donahue, R. E., Read, E. J., Lederman, R. J. (2008). Intracoronary infusion of autologous mononuclear cells from bone marrow or granulocyte colony-stimulating factor-mobilized apheresis product may not improve remodelling, contractile function, perfusion, or infarct size in a swine model of large myocardial infarction. Eur Heart J 29: 1772-1782 [Abstract] [Full Text]  
• Hung, T.-C., Suzuki, Y., Urashima, T., Caffarelli, A., Hoyt, G., Sheikh, A. Y., Yeung, A. C., Weissman, I., Robbins, R. C., Bulte, J. M., Yang, P. C. (2008). Multimodality Evaluation of the Viability of Stem Cells Delivered Into Different Zones of Myocardial Infarction. Circ Cardiovasc Imaging 1: 6-13 [Abstract] [Full Text]  
• Zhao, T. C., Tseng, A., Yano, N., Tseng, Y., Davol, P. A., Lee, R. J., Lum, L. G., Padbury, J. F. (2008). Targeting human CD34+ hematopoietic stem cells with anti-CD45 x anti-myosin light-chain bispecific antibody preserves cardiac function in myocardial infarction. J. Appl. Physiol. 104: 1793-1800 [Abstract] [Full Text]  
• Veltman, C. E., Soliman, O. I.I., Geleijnse, M. L., Vletter, W. B., Smits, P. C., ten Cate, F. J., Jordaens, L. J., Balk, A. H.H.M., Serruys, P. W., Boersma, E., van Domburg, R. T., van der Giessen, W. J. (2008). Four-year follow-up of treatment with intramyocardial skeletal myoblasts injection in patients with ischaemic cardiomyopathy. Eur Heart J 29: 1386-1396 [Abstract] [Full Text]  
• Nelson, T. J., Faustino, R. S., Chiriac, A., Crespo-Diaz, R., Behfar, A., Terzic, A. (2008). CXCR4+/FLK-1+ Biomarkers Select a Cardiopoietic Lineage from Embryonic Stem Cells. Stem Cells 26: 1464-1473 [Abstract] [Full Text]  
• Zampetaki, A., Kirton, J. P., Xu, Q. (2008). Vascular repair by endothelial progenitor cells. Cardiovasc Res 78: 413-421 [Abstract] [Full Text]  
• Gerosa, G., d'Agostino, C. (2008). Cell therapy in ischemic settings: Fact and fiction.. J. Thorac. Cardiovasc. Surg. 135: 986-990 [Full Text]  
• Kalka, C, Baumgartner, I. (2008). Gene and stem cell therapy in peripheral arterial occlusive disease. Vasc Med 13: 157-172 [Abstract]  
• Kinnaird, T., Stabile, E., Zbinden, S., Burnett, M.-S., Epstein, S. E. (2008). Cardiovascular risk factors impair native collateral development and may impair efficacy of therapeutic interventions. Cardiovasc Res 78: 257-264 [Abstract] [Full Text]  
• Hinkel, R., El-Aouni, C., Olson, T., Horstkotte, J., Mayer, S., Muller;, S., Willhauck, M., Spitzweg, C., Gildehaus, F.-J., Munzing, W., Hannappel, E., Bock-Marquette, I., DiMaio, J. M., Hatzopoulos, A. K., Boekstegers, P., Kupatt, C. (2008). Thymosin {beta}4 Is an Essential Paracrine Factor of Embryonic Endothelial Progenitor Cell-Mediated Cardioprotection. Circulation 117: 2232-2240 [Abstract] [Full Text]  
• Chachques, J. C., Trainini, J. C., Lago, N., Cortes-Morichetti, M., Schussler, O., Carpentier, A. (2008). Myocardial Assistance by Grafting a New Bioartificial Upgraded Myocardium (MAGNUM Trial): Clinical Feasibility Study. Ann. Thorac. Surg. 85: 901-908 [Abstract] [Full Text]  
• Fazel, S. S., Chen, L., Angoulvant, D., Li, S.-H., Weisel, R. D., Keating, A., Li, R.-K. (2008). Activation of c-kit is necessary for mobilization of reparative bone marrow progenitor cells in response to cardiac injury. FASEB J. 22: 930-940 [Abstract] [Full Text]  
• Burt, R. K., Loh, Y., Pearce, W., Beohar, N., Barr, W. G., Craig, R., Wen, Y., Rapp, J. A., Kessler, J. (2008). Clinical Applications of Blood-Derived and Marrow-Derived Stem Cells for Nonmalignant Diseases. JAMA 299: 925-936 [Abstract] [Full Text]  
• Sieveking, D. P., Buckle, A., Celermajer, D. S., Ng, M. K.C. (2008). Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay.. J Am Coll Cardiol 51: 660-668 [Abstract] [Full Text]  
• Lunde, K., Solheim, S., Forfang, K., Arnesen, H., Brinch, L., Bjornerheim, R., Ragnarsson, A., Egeland, T., Endresen, K., Ilebekk, A., Mangschau, A., Aakhus, S. (2008). Anterior myocardial infarction with acute percutaneous coronary intervention and intracoronary injection of autologous mononuclear bone marrow cells: safety, clinical outcome, and serial changes in left ventricular function during 12-months' follow-up.. J Am Coll Cardiol 51: 674-676 [Full Text]  
• Hashemi, S. M., Ghods, S., Kolodgie, F. D., Parcham-Azad, K., Keane, M., Hamamdzic, D., Young, R., Rippy, M. K., Virmani, R., Litt, H., Wilensky, R. L. (2008). A placebo controlled, dose-ranging, safety study of allogenic mesenchymal stem cells injected by endomyocardial delivery after an acute myocardial infarction. Eur Heart J 29: 251-259 [Abstract] [Full Text]  
• Tse, H.-F., Thambar, S., Kwong, Y.-L., Rowlings, P., Bellamy, G., McCrohon, J., Thomas, P., Bastian, B., Chan, J. K.F., Lo, G., Ho, C.-L., Chan, W.-S., Kwong, R. Y., Parker, A., Hauser, T. H., Chan, J., Fong, D. Y.T., Lau, C.-P. (2007). Prospective randomized trial of direct endomyocardial implantation of bone marrow cells for treatment of severe coronary artery diseases (PROTECT-CAD trial). Eur Heart J 28: 2998-3005 [Abstract] [Full Text]  
• Zhang, S. J., Wu, J. C. (2007). Comparison of Imaging Techniques for Tracking Cardiac Stem Cell Therapy. JNM 48: 1916-1919 [Full Text]  
• Rota, M., Kajstura, J., Hosoda, T., Bearzi, C., Vitale, S., Esposito, G., Iaffaldano, G., Padin-Iruegas, M. E., Gonzalez, A., Rizzi, R., Small, N., Muraski, J., Alvarez, R., Chen, X., Urbanek, K., Bolli, R., Houser, S. R., Leri, A., Sussman, M. A., Anversa, P. (2007). Bone marrow cells adopt the cardiomyogenic fate in vivo. Proc. Natl. Acad. Sci. USA 104: 17783-17788 [Abstract] [Full Text]  
• Tongers, J., Losordo, D. W. (2007). Frontiers in Nephrology: The Evolving Therapeutic Applications of Endothelial Progenitor Cells. J. Am. Soc. Nephrol. 18: 2843-2852 [Abstract] [Full Text]  
• Lipinski, M. J., Biondi-Zoccai, G. G.L., Abbate, A., Khianey, R., Sheiban, I., Bartunek, J., Vanderheyden, M., Kim, H.-S., Kang, H.-J., Strauer, B. E., Vetrovec, G. W. (2007). Impact of Intracoronary Cell Therapy on Left Ventricular Function in the Setting of Acute Myocardial Infarction: A Collaborative Systematic Review and Meta-Analysis of Controlled Clinical Trials. J Am Coll Cardiol 50: 1761-1767 [Abstract] [Full Text]  
• Doyle, B., Kemp, B. J., Chareonthaitawee, P., Reed, C., Schmeckpeper, J., Sorajja, P., Russell, S., Araoz, P., Riederer, S. J., Caplice, N. M. (2007). Dynamic Tracking During Intracoronary Injection of 18F-FDG-Labeled Progenitor Cell Therapy for Acute Myocardial Infarction. JNM 48: 1708-1714 [Abstract] [Full Text]  
• Khan, M., Kutala, V. K., Vikram, D. S., Wisel, S., Chacko, S. M., Kuppusamy, M. L., Mohan, I. K., Zweier, J. L., Kwiatkowski, P., Kuppusamy, P. (2007). Skeletal myoblasts transplanted in the ischemic myocardium enhance in situ oxygenation and recovery of contractile function. Am. J. Physiol. Heart Circ. Physiol. 293: H2129-H2139 [Abstract] [Full Text]  
• Yildirim, Y., Naito, H., Didie, M., Karikkineth, B. C., Biermann, D., Eschenhagen, T., Zimmermann, W.-H. (2007). Development of a Biological Ventricular Assist Device: Preliminary Data From a Small Animal Model. Circulation 116: I-16-I-23 [Abstract] [Full Text]  
• Ripa, R. S., Haack-Sorensen, M., Wang, Y., Jorgensen, E., Mortensen, S., Bindslev, L., Friis, T., Kastrup, J. (2007). Bone Marrow Derived Mesenchymal Cell Mobilization by Granulocyte-Colony Stimulating Factor After Acute Myocardial Infarction: Results From the Stem Cells in Myocardial Infarction (STEMMI) Trial. Circulation 116: I-24-I-30 [Abstract] [Full Text]  
• Gibbons, R. J., Araoz, P. A., Williamson, E. E. (2007). The Year in Cardiac Imaging. J Am Coll Cardiol 50: 988-1003 [Full Text]  
• Egeland, T., Brinchmann, J. E. (2007). The REPAIR-AMI and ASTAMI trials: cell isolation procedures. Eur Heart J 28: 2174-2175 [Full Text]  
• Zeiher, A. M., Schachinger, V., Dimmeler, S., For the REPAIR-AMI Investigators, (2007). Improved clinical outcome after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial: reply. Eur Heart J 28: 2173-2174 [Full Text]  
• Egeland, T., Brinchmann, J. E. (2007). Cell quality in the ASTAMI study. Eur Heart J 28: 2172-2172 [Full Text]  
• Simpson, D., Liu, H., Fan, T.-H. M., Nerem, R., Dudley, S. C. Jr. (2007). A Tissue Engineering Approach to Progenitor Cell Delivery Results in Significant Cell Engraftment and Improved Myocardial Remodeling. Stem Cells 25: 2350-2357 [Abstract] [Full Text]  
• Tomescot, A., Leschik, J., Bellamy, V., Dubois, G., Messas, E., Bruneval, P., Desnos, M., Hagege, A. A., Amit, M., Itskovitz, J., Menasche, P., Puceat, M. (2007). Differentiation In Vivo of Cardiac Committed Human Embryonic Stem Cells in Postmyocardial Infarcted Rats. Stem Cells 25: 2200-2205 [Abstract] [Full Text]  
• Breitbach, M., Bostani, T., Roell, W., Xia, Y., Dewald, O., Nygren, J. M., Fries, J. W. U., Tiemann, K., Bohlen, H., Hescheler, J., Welz, A., Bloch, W., Jacobsen, S. E. W., Fleischmann, B. K. (2007). Potential risks of bone marrow cell transplantation into infarcted hearts. Blood 110: 1362-1369 [Abstract] [Full Text]  
• Erbs, S., Linke, A., Schachinger, V., Assmus, B., Thiele, H., Diederich, K.-W., Hoffmann, C., Dimmeler, S., Tonn, T., Hambrecht, R., Zeiher, A. M., Schuler, G. (2007). Restoration of Microvascular Function in the Infarct-Related Artery by Intracoronary Transplantation of Bone Marrow Progenitor Cells in Patients With Acute Myocardial Infarction: The Doppler Substudy of the Reinfusion of Enriched Progenitor Cells and Infarct Remodeling in Acute Myocardial Infarction (REPAIR-AMI) Trial. Circulation 116: 366-374 [Abstract] [Full Text]  
• Dixon, S. R., Grines, C. L., O'Neill, W. W. (2007). The Year in Interventional Cardiology. J Am Coll Cardiol 50: 270-285 [Full Text]  
• Penicka, M., Horak, J., Kobylka, P., Pytlik, R., Kozak, T., Belohlavek, O., Lang, O., Skalicka, H., Simek, S., Palecek, T., Linhart, A., Aschermann, M., Widimsky, P. (2007). Intracoronary Injection of Autologous Bone Marrow-Derived Mononuclear Cells in Patients With Large Anterior Acute Myocardial Infarction: A Prematurely Terminated Randomized Study. J Am Coll Cardiol 49: 2373-2374 [Full Text]  
• Tse, H.-F., Lau, C.-P. (2007). Therapeutic Angiogenesis With Bone Marrow--Derived Stem Cells. J CARDIOVASC PHARMACOL THER 12: 89-97 [Abstract]  
• Abdel-Latif, A., Bolli, R., Tleyjeh, I. M., Montori, V. M., Perin, E. C., Hornung, C. A., Zuba-Surma, E. K., Al-Mallah, M., Dawn, B. (2007). Adult Bone Marrow-Derived Cells for Cardiac Repair: A Systematic Review and Meta-analysis. Arch Intern Med 167: 989-997 [Abstract] [Full Text]  
• Prockop, D. J., Olson, S. D. (2007). Clinical trials with adult stem/progenitor cells for tissue repair: let's not overlook some essential precautions. Blood 109: 3147-3151 [Full Text]  
• Lehman, R. (2007). Evidently . . .. Evid. Based Med. 12: 35-35 [Full Text]  
• (2007). Other articles noted. Evid. Based Med. 12: 63-64 [Full Text]  
• Beeres, S. L.M.A., Bengel, F. M., Bartunek, J., Atsma, D. E., Hill, J. M., Vanderheyden, M., Penicka, M., Schalij, M. J., Wijns, W., Bax, J. J. (2007). Role of Imaging in Cardiac Stem Cell Therapy. J Am Coll Cardiol 49: 1137-1148 [Abstract] [Full Text]  
• Zhang, S., Shpall, E., Willerson, J. T., Yeh, E. T.H. (2007). Fusion of Human Hematopoietic Progenitor Cells and Murine Cardiomyocytes Is Mediated by {alpha}4{beta}1 Integrin/Vascular Cell Adhesion Molecule-1 Interaction. Circ. Res. 100: 693-702 [Abstract] [Full Text]  
• Dawn, B., Bolli, R. (2007). Bone marrow for cardiac repair: the importance of characterizing the phenotype and function of injected cells. Eur Heart J 0: ehm009v1-2 [Full Text]  
• Seeger, F. H., Tonn, T., Krzossok, N., Zeiher, A. M., Dimmeler, S. (2007). Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction. Eur Heart J 28: 766-772 [Abstract] [Full Text]  
• Hu, X., Wang, J., Chen, J., Luo, R., He, A., Xie, X., Li, J. (2007). Optimal temporal delivery of bone marrow mesenchymal stem cells in rats with myocardial infarction. Eur. J. Cardiothorac. Surg. 31: 438-443 [Abstract] [Full Text]  
• Wisel, S., Chacko, S. M., Kuppusamy, M. L., Pandian, R. P., Khan, M., Kutala, V. K., Burry, R. W., Sun, B., Kwiatkowski, P., Kuppusamy, P. (2007). Labeling of skeletal myoblasts with a novel oxygen-sensing spin probe for noninvasive monitoring of in situ oxygenation and cell therapy in heart. Am. J. Physiol. Heart Circ. Physiol. 292: H1254-H1261 [Abstract] [Full Text]  
• Lindsay, A. (2007). JournalScan. Heart 93: 143-144 [Full Text]  
• Leone, A. M., Crea, F. (2006). Stem cells in acute myocardial infarction: the good, the bad, and the ugly. Eur Heart J 27: 2911-2913 [Full Text]  
• Moelker, A. D., Baks, T., van den Bos, E.J., van Geuns, R.J., de Feyter, P.J., Duncker, D. J., van der Giessen, W.J. (2006). Reduction in infarct size, but no functional improvement after bone marrow cell administration in a porcine model of reperfused myocardial infarction. Eur Heart J 27: 3057-3064 [Abstract] [Full Text]  
• Schachinger, V., Erbs, S., Elsasser, A., Haberbosch, W., Hambrecht, R., Holschermann, H., Yu, J., Corti, R., Mathey, D. G., Hamm, C. W., Suselbeck, T., Werner, N., Haase, J., Neuzner, J., Germing, A., Mark, B., Assmus, B., Tonn, T., Dimmeler, S., Zeiher, A. M., for the REPAIR-AMI Investigators, (2006). Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. Eur Heart J 27: 2775-2783 [Abstract] [Full Text]  
• Sanchez, P. L., Villa, A., San Roman, J. A., Cantero, T., Fernandez, M. E., Fernandez-Aviles, F. (2006). Percutaneous bone-marrow-derived cell transplantation: clinical observations. Eur Heart J Suppl 8: H23-H31 [Abstract] [Full Text]  
• Zhou, R., Acton, P. D., Ferrari, V. A. (2006). Imaging Stem Cells Implanted in Infarcted Myocardium. J Am Coll Cardiol 48: 2094-2106 [Abstract] [Full Text]  
• (2006). Bone Marrow Cell Transfer After STEMI: Mixed Results. Journal Watch Cardiology 2006: 5-5 [Full Text]  
• Tonks, A. (2006). What's new in the other general journals. BMJ 333: 699-700 [Full Text]  
• (2006). Mixed Results from Intracoronary Infusions of Adult Stem Cells in CAD. JWatch General 2006: 3-3 [Full Text]  
• Rosenzweig, A. (2006). Cardiac cell therapy--mixed results from mixed cells.. NEJM 355: 1274-1277 [Full Text]